Accelerate Diagnostics, Inc.

Accelerate Diagnostics has submitted its Accelerate WAVE system and positive blood culture gram-negative test kit to the FDA for 510(k) clearance. The WAVE system is designed to provide rapid antimicrobial susceptibility testing, enabling faster targeted antimicrobial therapy for patients with serious infections.

Related tickers: AXDX.

The global antimicrobial susceptibility testing market is projected to grow at a CAGR of 3.6% from 2025 to 2035, reaching $4.8 billion by 2035. The growth is driven by rising antibiotic resistance, advancements in diagnostic technologies, and government initiatives to combat antimicrobial resistance.

Related tickers: DHR, TMO, BIO, BIO.B, AXDX, RHHBY.